Administration of Medications by Pharmacists ; Authorizes pharmacists, at direction of certain licensed physicians, to administer medications; provides recordkeeping requirements; requires Board of Pharmacy to adopt rules; requires facilities to maintain documentation relating to pharmacist qualifications.
Drug Prices and Coverage; Requiring the Agency for Health Care Administration to contract with an entity to designate reference price source countries and analyze certain data; requiring the agency to publish annually prescription drug reference prices; prohibiting pharmacies from charging cash-paying customers more than the reference prices for prescribed drugs and biological products; requiring prescription drug manufacturer permitholders to annually report to the agency international drug price data beginning on a specified date; requiring certain health insurers to limit covered prescription drug reimbursement to reference prices, etc.
Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs; Prohibits drug manufacturers from engaging in certain acts against acquisitions of 340B drugs by & delivery of such drugs to specified pharmacies & from interfering with pharmacies' rights to contract with 340B entities; prohibits health insurance issuers, PBMs & other third-party payors, & agents, from engaging in discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibits health insurers & HMOs from engaging in discriminatory acts relating to reimbursement to 340B entities for 340B drugs; provides that each commission of certain acts constitutes violation of Florida Deceptive & Unfair Trade Practices Act & subjects violator to certain actions & penalties.
Insurer Disclosures on Prescription Drug Coverage; Requiring individual and group health insurers to provide notice of prescription drug formulary changes within a certain timeframe to current and prospective insureds and the insureds’ treating physicians; requiring insurers to maintain a record of formulary changes; defining the term “cost-sharing requirement”; providing an exception to requirements relating to changes in a health maintenance organization’s group contract, etc.
Pharmacy; Revising the definition of the term “health care facility” to include health care clinics owned by a hospital or physicians who work for a hospital; defining the term “covered prescription drug”; revising requirements for provider contracts between pharmacy benefit managers and certain licensed pharmacies to allow for the administration and dispensing of covered prescription drugs offsite, as well as onsite, as part of outpatient care, etc.
Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs; Prohibiting drug manufacturers from engaging in certain acts relating to the acquisition of 340B drugs by and the delivery of such drugs to specified pharmacies; prohibiting health insurance issuers, pharmacy benefit managers, and other third-party payors, and agents thereof, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibiting individual health insurers, group, blanket, and franchise health insurers, and health maintenance organizations, respectively, and pharmacy benefit managers on behalf of such insurers and health maintenance organizations, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs, etc.
Licensure of Medical Spas; Requires medical spas to be licensed; provides licensure requirements; requires Board of Pharmacy to maintain public database of licensed medical spas; provides database requirements; provides that medical spa is dispenser; prohibits medical spa from acquiring or receiving certain prescription medications; provides storage requirements for prescription medications & certain devices; requires medical spas to have certain security controls; requires medical spas to designate responsible person; provides requirements for responsible person; provides that submission of application for licensure by medical spa constitutes permission for inspections; provides requirements for inspections; requires medical spas to notify board of any adverse incidents within specified time frame; provides notice requirements; provides that violation of specified provisions constitutes unfair & deceptive trade practice; authorizes board to investigate certain violations & provide penalties; provides rulemaking authority.
Licensure of Medical Spas; Creating the “Medical Spa Prescription Drug Oversight Act”; requiring medical spas to be licensed under certain circumstances; requiring the Board of Pharmacy to maintain a public database of licensed medical spas; providing that submission of an application for licensure by a medical spa constitutes permission for inspections; authorizing the board to investigate certain violations and impose penalties, etc.
Pharmacy Audits; Revises requirements for audits of licensed pharmacies conducted by or on behalf of pharmacy benefit plans or programs; revises audit procedures, documentation requirements, recoupment limits, & reporting & appeal requirements; provides procedures for conducting audits of fraud, waste, or abuse; provides for enforcement; authorizes OIR to impose fines & other administrative penalties; authorizes suspension or revocation of pharmacy benefit manager's registration; requires FSC to adopt rules.
Consultant Pharmacists ; Revises definition of "health care facility"; authorizes consultant pharmacists to provide medication management services in clinics owned by hospital or by one or more physicians who are employed by or contracted with hospital.
